Ulysses Neuroscience Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $542K

  • Investors
  • 3

Ulysses Neuroscience General Information

Description

Operator of a biotechnology company intended to research rare neurodevelopmental, psychiatric and neurodegenerative disorders. The company offers patient-centric and translational research to bridge clinical and preclinical research, enabling researchers to advance knowledge and treatment of these disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Pioneer Life Sciences Cherrywood, Building 10
  • Cherrywood Business Park, Loughlinstown
  • Dublin
  • Northern Ireland, United Kingdom
+44 0387
Primary Industry
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Pioneer Life Sciences Cherrywood, Building 10
  • Cherrywood Business Park, Loughlinstown
  • Dublin
  • Northern Ireland, United Kingdom
+44 0387

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ulysses Neuroscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 14-Mar-2024 $542K Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view Ulysses Neuroscience’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ulysses Neuroscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to research rare neurodevelopmental, psychiatric and neurodegenerative diso
Other Pharmaceuticals and Biotechnology
Dublin, United Kingdom
13 As of 2025

La Gaude, France
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ulysses Neuroscience Competitors (9)

One of Ulysses Neuroscience’s 9 competitors is Iris Pharma, a Corporate Backed or Acquired company based in La Gaude, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iris Pharma Corporate Backed or Acquired La Gaude, France
Transpharmation Corporate Backed or Acquired London, United Kingdom
Excelya Private Equity-Backed Paris, France
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
Porsolt Private Equity-Backed Le Genest-Saint-Isle, France
You’re viewing 5 of 9 competitors. Get the full list »

Ulysses Neuroscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ulysses Neuroscience Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Enterprise Ireland Growth/Expansion Minority
Growing Capital Venture Capital Minority
Pioneer Group Venture Capital Minority
To view Ulysses Neuroscience’s complete investors history, request access »

Ulysses Neuroscience FAQs

  • When was Ulysses Neuroscience founded?

    Ulysses Neuroscience was founded in 2019.

  • Where is Ulysses Neuroscience headquartered?

    Ulysses Neuroscience is headquartered in Dublin, United Kingdom.

  • What is the size of Ulysses Neuroscience?

    Ulysses Neuroscience has 13 total employees.

  • What industry is Ulysses Neuroscience in?

    Ulysses Neuroscience’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Ulysses Neuroscience a private or public company?

    Ulysses Neuroscience is a Private company.

  • What is Ulysses Neuroscience’s current revenue?

    The current revenue for Ulysses Neuroscience is .

  • How much funding has Ulysses Neuroscience raised over time?

    Ulysses Neuroscience has raised $542K.

  • Who are Ulysses Neuroscience’s investors?

    Enterprise Ireland, Growing Capital, and Pioneer Group have invested in Ulysses Neuroscience.

  • Who are Ulysses Neuroscience’s competitors?

    Iris Pharma, Transpharmation, Excelya, Charles River Laboratories International, and Porsolt are some of the 9 competitors of Ulysses Neuroscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process